Blue Jet Healthcare shares fall sharply over 7% after weak Q3 results; Profit and revenue decline sharply

Shares of Blue Jet Healthcare Ltd came under heavy selling pressure on February 13 (IST), falling more than 7% in intraday trade after the company reported a sharp decline in its December quarter (Q3 FY26) earnings. The weak financial performance, marked by a steep drop in profit, revenue and operating margins, weighed heavily on investor sentiment.

For the third quarter, the company reported a net profit of ₹99 crore, down 59.6% year-on-year compared to ₹40 crore in the same period last year. The significant contraction in profitability reflects pressure on both topline growth and operating performance during the quarter.

Revenue from operations also declined sharply, falling 39.6% to ₹192.4 crore from ₹318.3 crore reported in Q3 of the previous financial year. The drop in revenue suggests subdued demand and lower business volumes during the period under review.

Operating performance mirrored the overall weakness. EBITDA fell 62.2% year-on-year to ₹47 crore compared to ₹124 crore in the corresponding quarter last year. The EBITDA margin contracted substantially to 24.3% from 39%.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.